A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Nine years follow-up after TVT-O; the mesh still available for women suffering from urinary incontinence
Tekijät: Warro Aino, Ojala Johanna, Ala-Nissilä Seija, Laurikainen Eija
Kustantaja: ELSEVIER MASSON, CORP OFF
Julkaisuvuosi: 2023
Journal: Journal of gynecology obstetrics and human reproduction
Tietokannassa oleva lehden nimi: JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION
Lehden akronyymi: J GYNECOL OBSTET HUM
Artikkelin numero: 102534
Vuosikerta: 52
Numero: 3
Sivujen määrä: 6
ISSN: 2468-7847
DOI: https://doi.org/10.1016/j.jogoh.2023.102534
Verkko-osoite: https://doi.org/10.1016/j.jogoh.2023.102534
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/178862904
Objective: The efficacy of TVT-O is well established in patients with stress urinary incontinence (SUI). The objective of this study was to evaluate the efficacy, safety and patient satisfaction of TVT-O in patients suffer-ing from primary or recurrent SUI or mixed urinary incontinence (MUI).
Methods: A single-center follow-up study was conducted. All consecutive women treated by TVT-O between August 2004 and October 2011 were included. Objective treatment success was a negative stress test. Patient satisfaction was assessed by questionnaires.
Results: The mean time from the surgery to the last follow-up visit was 9 years. One hundred and six patients were included in the final evaluation. Nineteen patients (18%) were previously operated on for urinary incon-tinence (UI). Ninety patients (85%) were objectively cured; 68 (89%) of the SUI and 22 (73%) of the MUI patients (p = 0.067). Fourteen (74%) of the previously operated patients and 76 (87%) of the patients who underwent first-time TVT-O were objectively cured (p = 0.158). Eighty-six patients (81%) achieved subjective success; 70 (92%) of the SUI and sixteen (53%) of the MUI patients (p<0.001). Eleven women (58%) who had repeat surgery and 75 women (86%) who had primary operation were subjectively cured (p = 0.008).
Conclusions: TVT-O is effective in women who suffer from SUI having 90% objective and subjective cure rate 9 years after surgery. There were no major complications, but 16% of the women suffered from groin pain and 37% had urgency symptoms. The results of TVT-O were still good, and it is a therapeutic alternative for different subgroups of UI including recurrent cases.
(c) 2023 The Authors. Published by Elsevier Masson SAS.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
Ladattava julkaisu This is an electronic reprint of the original article. |